What are SANUWAVE Health, Inc.'s total assets?

SANUWAVE Health, Inc. (SNWV) holds $37.1M in total assets, up 20.2% year over year.

How much debt does SANUWAVE Health, Inc. have?

SANUWAVE Health, Inc. carries $21.7M in total debt against $1.8M of shareholders' equity, a debt-to-equity ratio of 11.79.

How much cash does SANUWAVE Health, Inc. have?

SANUWAVE Health, Inc. holds $10.8M in cash and equivalents.

Can SANUWAVE Health, Inc. cover its short-term obligations?

Its current ratio is 1.31 — current assets exceed current liabilities.

Where does SANUWAVE Health, Inc.'s balance sheet data come from?

Every line is extracted from SANUWAVE Health, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

SANUWAVE Health, Inc. SNWV Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Cash and cash equivalents	$10.78M+26.8%	$11.96M+16.8%	$9.6M+195%	$8.5M+245%	$8.5M+190%
Accounts receivable, net	$6M+55.2%	$5.42M+62.9%	$4.62M+62.9%	$3.85M+22.0%	$3.87M+28.5%
Inventories	$5.9M+8.2%	$5.93M+43.0%	$6.81M+98.6%	$5.91M+116%	$5.46M+122%
Raw materials	$128K-97.5%	$135K-96.4%	$731K—	$2.71M—	$5.08M—
Finished goods	$5.99M+1,468%	$6.01M+1,458%	$6.08M—	$3.2M—	$382K—
Prepaid expenses and other current assets	$1.27M+26.5%	$1.31M+92.4%	$1.6M+322%	$1.91M+405%	$1.01M-58.5%
Total current assets	$23.96M+27.2%	$24.63M+33.9%	$22.63M+129%	$20.17M+131%	$18.83M+73.9%
Property and equipment, net	$1.91M+326%	$1.97M+551%	$1.99M+158%	$1.59M+67.6%	$449K-53.9%
Operating lease right-of-use assets	$991K+148%	$390K-9.1%	$431K—	$653K—	$400K—
Goodwill	$7.26M0.0%	$7.26M0.0%	$7.26M0.0%	$7.26M0.0%	$7.26M0.0%
Intangible assets, net	$2.92M-17.9%	$3.03M-18.9%	$3.2M-18.0%	$3.38M-17.2%	$3.55M-16.5%
Total noncurrent assets	$13.14M+9.3%	$12.72M+8.5%	$12.97M+8.6%	$12.88M+4.8%	$12.02M-3.8%
Total assets	$37.1M+20.2%	$37.34M+24.0%	$35.6M+63.0%	$33.05M+57.3%	$30.86M+32.3%
Accounts payable	$3.32M-20.0%	$3.25M-12.8%	$3.99M-3.5%	$4M+2.9%	$4.15M-18.0%
Accrued expenses	$961K-5.4%	$1.22M+3,597%	$1.04M-50.3%	$906K-49.9%	$1.02M-58.5%
Deferred revenue	$487K+151%	$388K+101%	$299K+118%	$231K+77.7%	$194K+81.3%
Current portion of long-term debt	$5.75M—	$0-100%	$5.75M—	$115K—	——
Operating lease liabilities, current	$300K+14.5%	$157K+24.6%	$191K—	$82K—	$262K—
Accrued interest	$23K—	$24K—	——	——	——
Total current liabilities	$18.3M-64.0%	$17.85M-60.7%	$23.99M-70.6%	$50.42M-15.9%	$50.78M-27.6%
Long-term debt	$14.33M—	$15.67M—	$17.08M—	——	——
Operating Lease Liabilities (Total)	$1.59M+299%	$1.01M—	$1.09M—	$1.06M—	$400K—
Other non-current liabilities	$676K+112%	$701K—	$575K+60.6%	$34K-90.3%	$319K-6.2%
Total noncurrent liabilities	$16.96M+1,829%	$17.88M+3,541%	$18.95M+3,091%	$1.32M+102%	$879K+19.6%
Total liabilities	$35.26M-31.8%	$35.72M-22.2%	$43.19M-47.4%	$51.85M-14.5%	$51.67M-27.1%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	2.5B0.0%	2.5B+27,777,678%	2.5B0.0%	2.5B0.0%	2.5B0.0%
Additional paid-in capital	$245.94M+2.6%	$244.29M+2.3%	$242.77M+36.1%	$241.25M+36.1%	$239.79M+36.4%
Retained earnings	-$244.12M+6.3%	-$242.69M+4.6%	-$250.38M-4.9%	-$260.07M-19.3%	-$260.62M-16.0%
Accumulated other comprehensive income (loss)	$10K0.0%	$10K0.0%	$10K0.0%	$10K0.0%	$10K—
Total stockholders' equity	$1.84M+109%	$1.62M+110%	-$7.59M+87.4%	-$18.8M+52.5%	-$20.81M+56.3%
Total liabilities and stockholders' equity	$37.1M+20.2%	$37.34M+24.0%	$35.6M+63.0%	$33.05M+57.3%	$30.86M+32.3%
Allowance for Doubtful Accounts	$1.31M+10.6%	$1.27M+10.3%	$1.26M+19.2%	$1.28M+7.0%	$1.18M-4.6%
Allowance for Doubtful Accounts Receivable (Current)	$1.31M+10.6%	$1.27M+10.3%	$1.26M+19.2%	$1.28M+7.0%	$1.18M-4.6%
Other Inventory, Net	$213K—	$213K—	——	——	——
Net Investment in Lease	$991K+148%	$390K-9.1%	$431K—	$653K—	$400K—
Other intangible assets—net	$2.92M-17.9%	$3.03M-18.9%	$3.2M-18.0%	$3.38M-17.2%	$3.55M-16.5%
Operating lease right-of-use assets	$991K+148%	$390K-9.1%	$431K—	$653K—	$400K—
Operating Lease Right-of-Use Assets in Other Assets	$991K+148%	$390K-9.1%	$431K—	$653K—	$400K—
Accrued liabilities and other current	$16K—	$32K—	——	——	——
Accrued Manufacturing Costs	$961K-5.4%	$1.22M-45.3%	$1.04M-50.3%	$906K-49.9%	$1.02M-58.5%
Accrued Progress Collections and Price Adjustments	$676K+112%	$701K+134%	$575K+60.6%	$410K+17.1%	$319K-6.2%
Other Commercial Liabilities	$8.58M+21.0%	$8.38M+8.1%	$7.95M+51.6%	$7.19M+50.1%	$7.09M+3.5%
Accrued Liabilities, Current	$8.58M+21.0%	$8.38M+8.1%	$7.95M+51.6%	$7.19M+50.1%	$7.09M+3.5%
Compensation and benefits	$961K-5.4%	$1.22M-45.3%	$1.04M-50.3%	$906K-49.9%	$1.02M-58.5%
Other accrued liabilities	$5K-86.1%	$7K-78.8%	$6K-98.4%	$0-100%	$36K-96.3%
Current portion of Term Loan	$5.59M—	$5.64M—	$5.63M—	——	——
Lease Liability Payments - 2020 (Remaining Three Months)	$299K—	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	$441K+34.5%	——	$272K—	$328K—	$328K—
Operating Lease Liability Payments - 2025 (Lessee)	$473K+62.0%	——	$292K—	$292K—	$292K—
Lease Liability Payments - Due Year Two	$441K+34.5%	——	$272K—	$328K—	$328K—
Lease Liability Payments - Due Year Three	$456K+61.7%	——	$282K—	$282K—	$282K—
Lease Liability Payments - Due Year Four	$473K+62.0%	——	$292K—	$292K—	$292K—
Lease Liability Payments - Remainder of Fiscal Year	$112K-67.5%	——	$270K—	$345K—	$345K—
Operating Lease Liability Payments Due	$1.94M+85.3%	——	$1.41M—	$1.43M—	$1.05M—
Operating Lease Liability - Undiscounted Excess Amount	$346K-13.7%	——	$326K—	$377K—	$401K—
Professional Service Fees Payable	$172K-51.0%	$172K-30.9%	$172K-85.6%	$172K-85.7%	$351K-67.3%
Sales taxes payable	$4.19M—	$3.89M—	——	——	——
Contract Liabilities, Non-Current	$676K+112%	$701K+134%	$575K+60.6%	$410K+17.1%	$319K-6.2%
Debt Instrument Face Amount	$655K—	$655K—	$655K-92.8%	——	——
Debt Maturity - 2027	$5.75M—	——	$5.75M—	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$268K—	——	$371K-77.4%	——	——
Operating Lease Liability Payments - 2026 (Lessee)	$456K+61.7%	——	$282K—	$282K—	$282K—
Operating Lease Liability Payments - 2027 (Lessee)	$456K+61.7%	——	$282K—	$282K—	$282K—
Operating Lease Liability Payments - 2028 (Lessee)	$473K+62.0%	——	$292K—	$292K—	$292K—
Deferred revenue, net of current portion	$676K+112%	$701K+134%	$575K+60.6%	$410K+17.1%	$319K-6.2%
Operating lease liabilities, less current portion	$1.29M—	$854K+583%	$897K—	$974K—	——
Total debt	$21.67M+5,319%	$16.68M+4,444%	$23.92M—	$1.18M—	$400K—
Total Carrying Value of Debt	$20.78M—	——	$23.66M—	——	——
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Issued	8.6M+0.5%	8.6M+0.5%	8.6M+172%	8.6M-99.3%	8.5M-99.3%
Common Stock Shares Outstanding	$2.39M-89.6%	$13.35M+43.5%	$24.1M—	$18.86M—	$22.88M—
Convertible Preferred Stock Authorized Shares	5M0.0%	5M0.0%	5M0.0%	5M0.0%	5M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$9K0.0%	$9K0.0%	$9K+200%	$9K-99.2%	$9K-99.2%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Number of Exercisable Options	625K+202%	——	402K—	292K—	207K—
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment Award Options Outstanding - Number	1.5M+21.8%	1.4M+20.7%	1.4M—	1.3M—	1.2M—
Share-Based Payment - Unrecognized Cost of Nonvested Awards	$10.8M+21.3%	——	$10.1M—	$9.9M—	$8.9M—
Weighted Average Exercise Price of Outstanding Options	$22.16+27.6%	$21.46+34.4%	$19.03—	$17.53—	$17.37—
Professional service fees	$172K-51.0%	$172K-30.9%	$172K-85.6%	$172K-85.7%	$351K-67.3%
Registration penalties	$1.58M0.0%	$1.58M0.0%	$1.58M0.0%	$1.58M0.0%	$1.58M0.0%
Accounts Receivable, Allowance for Credit Loss	$1.31M+10.6%	$1.27M+10.3%	$1.26M+19.2%	$1.28M+7.0%	$1.18M—
Allowance for doubtful accounts	$1.31M+10.6%	$1.27M+10.3%	$1.26M+19.2%	$1.28M+7.0%	$1.18M-4.6%
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$2.5B0.0%	$2.5B0.0%	$2.5B0.0%	$2.5B0.0%	$2.5B0.0%
Common stock, shares issued (in shares)	$8.59M+0.5%	$8.59M+0.5%	$8.58M+172%	$8.57M-99.3%	$8.55M-99.3%
Common Stock, Shares, Outstanding	$8.59M+0.5%	$8.59M+0.5%	$8.58M+172%	$8.57M-99.3%	$8.55M-99.3%
Long-term debt, gross	$20.78M—	——	$23.66M—	——	——
Deferred Finance Costs Noncurrent Net	$58K—	$68K—	$79K—	——	——
Unrecognized compensation cost related to non-vested awards	$10.8M+21.3%	——	$10.1M—	$9.9M—	$8.9M—
Raw materials	$128K-97.5%	$135K-96.4%	$731K—	$2.71M—	$5.08M—
Reimbursement payments receivable	$300K-48.8%	——	$586K—	$586K—	$586K—
Lessee Operating Lease Liability Payments Due	$1.94M+85.3%	——	$1.41M—	$1.43M—	$1.05M—
Thereafter	$159K-20.1%	——	$199K—	$199K—	$199K—
Lessee Operating Lease Liability Undiscounted Excess Amount	$346K-13.7%	——	$326K—	$377K—	$401K—
Amount outstanding under the credit facility	$655K—	$655K—	$655K—	——	——
2028	$6.41M—	——	$6.41M—	——	——
2029	$5.75M—	——	$5.75M—	——	——
2030	$4.31M—	——	$4.31M—	——	——
2027	$4.31M—	——	$5.75M—	——	——
Operating lease, incremental borrowing rate (as a percent)	7.2%-4.3%	——	——	——	11.5%—
Other accrued liabilities	$519K-17.7%	$487K-20.7%	$789K+114%	$628K+212%	$631K-26.0%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$5M0.0%	$5M0.0%	$5M0.0%	$5M0.0%	$5M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—	$0—
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	$625K+202%	——	$402K—	$292K—	$207K—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$1.5M+21.8%	$1.37M+20.7%	$1.35M—	$1.31M—	$1.23M—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$22.16+27.6%	$21.46+34.4%	$19.03—	$17.53—	$17.37—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$2.39M-89.6%	$13.35M+43.5%	$24.1M—	$18.86M—	$22.88M—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$20.11-7.8%	——	$25.15—	$19.95—	$21.82—
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	$1.25M-64.4%	——	$7.45M—	$4.33M—	$3.5M—
State & Local Sales Tax Interest	$554K—	$464K—	——	——	——
State & Local Sales Tax Penalties	$607K—	$571K—	——	——	——
Unrecorded Unconditional Purchase Obligation	$2.3M+64.3%	——	$1.4M—	$1.4M—	$1.4M—
Remainder of Fiscal Year 2024	$299K—	——	$1.44M—	——	——
Unrecorded Unconditional Purchase Obligation	$2.3M+64.3%	——	$1.4M—	$1.4M—	$1.4M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about SANUWAVE Health, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are SANUWAVE Health, Inc.'s total assets?: SANUWAVE Health, Inc. (SNWV) holds $37.1M in total assets, up 20.2% year over year.
How much debt does SANUWAVE Health, Inc. have?: SANUWAVE Health, Inc. carries $21.7M in total debt against $1.8M of shareholders' equity, a debt-to-equity ratio of 11.79.
How much cash does SANUWAVE Health, Inc. have?: SANUWAVE Health, Inc. holds $10.8M in cash and equivalents.
Can SANUWAVE Health, Inc. cover its short-term obligations?: Its current ratio is 1.31 — current assets exceed current liabilities.
Where does SANUWAVE Health, Inc.'s balance sheet data come from?: Every line is extracted from SANUWAVE Health, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.